DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

7.25 -0.10 (-1.29%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PGNX $7.25 -1.29%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.34
Previous Close $7.35
Daily Range $7.21 - $7.57
52-Week Range $3.10 - $7.57
Market Cap $504.3M
P/E Ratio 66.77
Dividend (Yield) $0.00 (0.0%)
Volume 6,108,494
Average Daily Volume 1,276,366
Current FY EPS $0.02

Sector

Healthcare

Industry

Drugs

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

The Biggest Risks For Stocks In 2015?

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Tiger Management's Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, ...

Progenics Pharmaceutical (PGNX) Upgraded From Sell to Hold

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker Q3 2014 Results - Earnings Call Transcript

Morning Market Movers

Looking For My Next Triple In Biotech

Phase 2 Data for Progenics' 1404 Imaging Agent Presented at EANM Congress

See More PGNX News...

PGNX's Top Competitors

PGNX $7.25 (-1.29%)
Current stock: PGNX
AMGN $170.17 (1.00%)
Current stock: AMGN
GILD $108.45 (2.76%)
Current stock: GILD
BIIB $360.67 (1.97%)
Current stock: BIIB